Follow

Submissions from 2024

An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice, Eyub Akdemir, Yazmin Odia, Matthew Hall, Minesh Mehta, and Rupesh Kotecha

Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease, Haley Appel, Muni Rubens, Mukesh Roy, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Zhijian Chen, Manmeet Ahluwalia, and Yazmin Odia

Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong

Quality assurance of an established online adaptive radiotherapy program: patch and software upgrade, Michael Chuong, Rupesh Kotecha, Yonatan Weiss, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer

SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Jerry George, Ranjini Tolakanahalli, Santiago Aguirre, Taehyung Kim, and Vivek Mishra

PDF

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Rupesh Kotecha

How proton therapy fits into the management of adult intracranial tumors, Rupesh Kotecha, Alonso La Rosa De Los Rios, and Minesh Mehta

In Regard to Trifiletti et al, Rupesh Kotecha and Minesh Mehta

Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, and Noah Kalman

Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press

PDF

Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors, Alonso La Rosa de los Rios, Kathryn Mittauer, Nema Bassiri-Gharb, Amy Rzepczynski, Michael Chuong, Sreenija Yarlagadda, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

The First Report of Using Low-Field MRI-Guided Radiation Therapy in a Patient With a Cochlear Implant, James McCulloch, Nema Bassiri Gharb, Alonso Gutierrez, Jennifer Armas, Kevin Abrams, Minesh Mehta, Michael Chuong, and Kathryn Mittauer

A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults, Minesh Mehta

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial, Minesh Mehta

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology, Minesh Mehta

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001, Minesh Mehta

Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta

Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614, Minesh Mehta

Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta

In Reply to Halperin, Minesh Mehta

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta

Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach, Minesh Mehta

Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton Therapy, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta

PDF

Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Kathryn Mittauer, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Nema Bassiri-Gharb

Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall

ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta

ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta

Proton Therapy: Current Status and Controversies, Robert Press and Minesh Mehta

Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial, Robert Rothrock, Maria Avendano, Susana Herrera, Haley Appel, Suyen Ramos, Amy Starosciak, Muni Rubens, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Submissions from 2023

Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Sandoval Leon, and Reshma Mahtani

Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis, Manmeet Ahluwalia and Minesh Mehta

Evaluating the Diagnostic Performance of Leptomeningeal Diagnosis with CNSide™ Compared to Standard Cytology, Haley Appel, Anshul Saxena PhD, Rupesh Kotecha, Alexander Mohler, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Yazmin Odia, and Serguei Castaneda

Commissioning Intracranial Stereotactic Radiosurgery (SRS) for an MR-GuidedRadiotherapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer

Management of Brain Metastases: A Review of Novel Therapies, Shreyas Bellur, Atulya Khosla, Rupesh Kotecha, Michael McDermott, and Manmeet Ahluwalia

"Good-Catches Inventory to Interactive Data-Repository: Management and Analysis for Process Improvement", Vibha Chaswal, Cecilia Lee, D Jay Wieczorek, Alonso Gutierrez, and Ranjini Tolakanahalli

Evaluation of a Flat-Panel Based Compact Daily Quality Assurance Device for PencilBeam Scanning Proton Therapy, Daniel Cho, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe

PDF

Advances in MRI-Guided Radiation Therapy, Michael Chuong

PDF

Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options, Michael Chuong

PDF

Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy, Michael Chuong

Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments, Michael Chuong

Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Long-term Outcomes from the Proton Collaborative Group Registry, Michael Chuong

Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy, Michael Chuong, Roberto Herrera, Antonio Ucar, Santiago Aparo, Fernando De Zarraga, Domenech Asbun, Javier Jimenez, Horacio Asbun, Govindarajan Narayanan, Sarah Joseph, Rupesh Kotecha, Matthew Hall, Kathryn Mittauer, Diane Alvarez, James McCulloch, Tino Romaguera, Alonso Gutierrez, and Adeel Kaiser

Prognostic value of neutrophil/lymphocyte count in pancreas patients receiving ablative MR-guided RT, Michael Chuong, Robert Herrera, Muni Rubens, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Sarah Joseph, Matthew Hall, Rupesh Kotecha, Adeel Kaiser, and Gigi Estevez

Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere

Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer, Michael Chuong, Nicole McAllister, Surya Chundru, Robert Herrera, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Kathryn Mittauer, Diane Alvarez, James McCulloch, Nema Bassiri-Gharb, Alonso Gutierrez, Nicolas Carvallo, and Jason Extein

Phase II Trial of Stereotactic MR-guided On-table Adaptive Radiation Therapy for Borderline or Locally Advanced Pacreatic Cancer: Updated Safety & Efficacy Outcomes, Michael Chuong and Kathryn Mittauer

Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial, Michael Chuong and Kathryn Mittauer

Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Guilherme Rabinowits, Muni Rubens, Alonso Gutierrez, Rupesh Kotecha, and Carolina Rojas

Prospective Study Phase II Trial of Stereotactic MRI-Guided Adaptive Radiotherapy in 1 Fraction: Unplanned Interim Analysis, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Muni Rubens, Alonso Gutierrez, and Rupesh Kotecha

Multi-institutional outcomes of proton beam therapy for hepatocellular carcinoma from the Proton Collaborative Group REG001-09 stud, Michael Chuong and Muni Rubens

Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Suggested planning approaches for prior irradiation patients, Zachary Fellows, Andrew Wroe, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez

PDF

Variable Relative Biological Effectiveness of Proton Therapy Increases PET-Visible Mucosal Injury in Head and Neck Cancer Patients, Edgar Gelover Reyes, Raees Tonse, Surya Chundru, Adeel Kaiser, Len Coutinho, Ryan Zielan, Zachary Fellows, and Noah Kalman

PDF

Integration and dosimetric validation of a dynamic collimation system for pencil beam scanning proton therapy, Alonso Gutiérrez

Assessment of set-up accuracy in breast patients treated with proton therapy when using surface imaging as compared to kV-based, Alonso Gutierrez, Andrew Wroe, and Daniel Cho

Dose-escalated proton therapy with concurrent and adjuvant immunotherapy for chordoma: early results and toxicities from a single institution case series, Matthew Hall

Multi-institutional experience of proton therapy for osteosarcoma in the Proton Collaborative Group (PCG) prospective registry, Matthew Hall, Keitrina Mair, and Katherine Von Werne

Dose-escalated proton therapy with concurrent and adjuvant immunotherapy for chordoma: Early results and toxicities from a single institution case series ​, Matthew Hall, Yazmin Odia, Minesh Mehta, Muni Rubens, Ranjini Tolakanahalli, Alonso Gutierrez, Keitrina Mair, Katherine Von Werne, and Carlos Rios

The A3i System Significantly Reduces Treatment Times for MRLinac Radiotherapy, Robert Herrera, Michael Chuong, Kathryn Mittauer, James McCulloch, Diane Alvarez, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Minesh Mehta, and Alonso Gutierrez

Dosimetric Comparison of GammaTile Implants to Stereotactic Radiotherap, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Vibha Chaswal, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, Ranjini Tolakanahalli, and Zachary Fellows

GammaTile® brachytherapy versus stereotactic radiotherapy: A dosimetric comparison for the treatment of recurrent brain metastasis resection cavities, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Dosimetric Comparison of GammaTile® Implants to Stereotactic Radiotherapy for Recurrent Brain Metastasis Resection Cavities., Robert Herrera, Rupesh Kotecha, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART), Roberto Herrera, Muni Rubens, Adeel Kaiser, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Horacio Asbun, Ramon Jimenez, and Michael Chuong

A machine learning based-personalized plan selection methodology for reducing skin toxicity in proton pencil beam scanning, Michael Kasper and Suresh Rana

Advancing Beyond the Hippocampus to Improve Cognition for Patients with Brain Metastases: An Initial Report of a Phase 2 Trial Examining Memory-Avoidance Whole Brain Radiotherapy, Rupesh Kotecha

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000 (NCT# 04511013). 2023 American Society of Clinical Oncology, Rupesh Kotecha

Clinical trial implementation: a primer for neurosurgeons, Rupesh Kotecha

Evaluating the diagnostic performance of 18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial. 2023, Rupesh Kotecha

PDF

ISRS Technical Guidelines for Stereotactic Radiosurgery: Treatment of Small Brain Metastases (≤1 cm in diameter), Rupesh Kotecha

Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha

PURSUE: results from a prospective, phase 2b trial to define image interpretation criteria for 18F-fluciclovine-PET for detection of recurrent brain metastases after radiation therapy, Rupesh Kotecha

PDF

Single-fraction radiosurgery outcomes for large vestibular schwannomas in the upfront or post-surgical setting: a systematic review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha

Tumor Treating Fields (TTFields) therapy with standard of care (SOC) systemic therapy in advanced non-small cell lung cancer (aNSCLC) following platinum failure: Final results of the phase 3, randomized LUNAR study, Rupesh Kotecha

Outcomes of MR-guided Stereotactic Body Radiotherapy (MRgSBRT) for adrenal metastases: A multi-institutional pooled analysis, Rupesh Kotecha and Tugce Kutuk

Evaluation of an interactive, multi-language, neurocognitive app in CNS radiation oncology, Rupesh Kotecha, Tugce Kutuk, Muni Rubens, Yazmin Odia, Matthew Hall, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, Suyen Ramos, and Miguel Ramirez Menendez

PDF

Evaluating the intracranial activity of adagrasib, Rupesh Kotecha, Alonso La Rosa de los Rios, Tugce Kutuk, Manmeet Ahluwalia, and Minesh Mehta

Surgically Targeted Radiation Therapy (STaRT) for brain metastases: Initial Experience from a Prospective Multi-institutional Registry, Rupesh Kotecha and Michael McDermott

Editorial: Effects of radiation therapies on brain metastases, Rupesh Kotecha and Minesh Mehta

PDF

Modern Meningioma Methods: Molecular Diagnostics and High Dose Protons, Rupesh Kotecha and Minesh Mehta

PDF

Rethinking classification and categorization of resection extent and its impact on patient survival in glioblastoma: Was Walter Dandy ahead of his time?, Rupesh Kotecha and Minesh Mehta

PDF

Key Clinical Principles in the Management of Glioblastoma, Rupesh Kotecha, Yazmin Odia, Atulya Khosla, and Manmeet Ahluwalia

Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Initial real-world clinical experience, Tugce Kutuk, Haley Appel, Zachary Fellows, Alonso La Rosa de los Rios, Yazmin Odia, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Rupesh Kotecha, and Sreenija Yarlagadda

Toxicity outcomes of dose-escalated MR-guided radiation therapy for abdominal and pelvic tumors, Tugce Kutuk, Michael Chuong, Kathryn Mittauer, Jessika Contreras, Adeel Kaiser, Matthew Hall, James McCulloch, Diane Alvarez, Minesh Mehta, Alonso Gutierrez, Rupesh Kotecha, Martin Tom, and Robert Herrera

The Initial Clinical Experience with an Interactive, Multi-Language, App-Based Neurocognitive Evaluation Program for Proton Therapy on CNS Malignancies, Tugce Kutuk, Rupesh Kotecha, Yazmin Odia, Matthew Hall, Haley Appel, Miguel Ramirez Menendez, Manmeet Ahluwalia, Minesh Mehta, and Alonso La Rosa de los Rios

Tumor treating fields: narrative review of a promising treatment modality for cancer, Tugce Kutuk, Alonso La Rosa De Los Rios, Rupesh Kotecha, Minesh Mehta, and Michael Chuong

Integration of an APP-based Neurocognitive Evaluation Program into Stereotactic Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational Study, Tugce Kutuk, Cecilia Lee, Yazmin Odia, Alonso La Rosa de los Rios, Matthew Hall, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Implementation of an Interactive, Multi-Language, App-Based Neurocognitive Evaluation Program into Routine Stereotactic Radiosurgery Practice, Tugce Kutuk, Yazmin Odia, Matthew Hall, Haley Appel, Miguel Ramirez Menendez, Alexander Mohler, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States, Tugce Kutuk, Muni Rubens, Haley Appel, Michael Chuong, Adeel Kaiser, Matthew Hall, Jessika Contreras, Minesh Mehta, and Rupesh Kotecha

Surgically Targeted Radiation Therapy (STaRT) For Recurrent Brain Metastases: Initial Clinical Experience, Tugce Kutuk, Ranjini Tolakanahalli, D Jay Wieczorek, Haley Appel, Alonso Gutierrez, Alonso La Rosa de los Rios, Robert Herrera, Michael McDermott, Vitaly Siomin, Minesh Mehta, and Rupesh Kotecha

A comparative evaluation of different radiosurgery management strategies for large brain metastases: What is the optimal treatment paradigm?, Tugce Kutuk, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Anshul Saxena, Alonso La Rosa de los Rios, Martin Tom, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy

Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis, Alonso La Rosa de los Rios, Surya Chundru, Martin Tom, Tugce Kutuk, D Jay Wieczorek, Muni Rubens, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

PDF

Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas, Alonso La Rosa de los Rios, Alonso Gutierrez, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Characterization of large brain metastases with 18F-Fluciclovine PET/CT treated with staged stereotactic radiosurgery (SSRS): interim analysis of a pilot study, Alonso La Rosa de los Rios, Tugce Kutuk, D Jay Wieczorek, Cecilia Lee, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Rupesh Kotecha, and Minesh Mehta

PDF

Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer, Alonso La Rosa de los Rios, Kathryn Mittauer, Michael Chuong, Matthew Hall, Tugce Kutuk, Nema Bassiri-Gharb, James McCulloch, Diane Alvarez, Raul Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

Treatment of glioblastoma using MRIdian® A3i BrainTx™: Imaging and treatment workflow demonstration, Alonso La Rosa De Los Rios, Kathryn Mittauer, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, James McCulloch, Diane Alvarez, Roberto Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases, Alonso La Rosa De Los Rios, D Jay Wieczorek, Ranjini Tolakanahalli, Cecilia Lee, Tugce Kutuk, Matthew Hall, Michael McDermott, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha

PDF

Implementation of superficial radiation therapy (SRT) using SRT-100 Vision™ for non-melanoma skin cancer in a Radiation Oncology clinic, Cecilia Lee, Stephan Davis, William Romaguera, Vibha Chaswal, Ranjini Tolakanahalli, Alonso Gutierrez, and Noah Kalman